Ulsan, South Korea

Yeon Jung Park


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yeon Jung Park: Innovator in Antifungal Agents

Introduction

Yeon Jung Park, an accomplished inventor based in Ulsan, South Korea, has made significant contributions to the field of pharmaceuticals with his innovative work focusing on antifungal agents. With 1 registered patent to his name, Yeon Jung Park is recognized for developing novel compounds that can combat fungal infections effectively.

Latest Patents

His notable patent, titled "Antifungal oxodihydropyridinecarbohydrazide derivative," introduces a new class of oxodihydropyridinecarbohydrazide derivatives that exhibit outstanding antifungal activities. This invention not only includes potent antifungal and fungicidal properties but also offers a composition that can be utilized for the prevention and treatment of various fungal infectious diseases. Importantly, these oxodihydropyridinecarbohydrazide derivatives can be administered orally, differentiating them from traditional fungicidal preparations.

Career Highlights

Yeon Jung Park is associated with Daewoong Pharmaceutical Co., Ltd., a leading pharmaceutical company in South Korea. His work at this company has allowed him to contribute significantly to research and development in the field of antifungal treatments. His innovative approach to drug formulation has garnered attention in the industry.

Collaborations

Throughout his career, Yeon Jung Park has collaborated with talented individuals such as Joon Seok Park and Youn Jung Yoon. These collaborations have strengthened the research efforts within his team, leading to advancements in pharmaceutical innovations.

Conclusion

Yeon Jung Park stands out as a valuable inventor whose dedication to improving antifungal therapies has the potential to benefit many suffering from fungal infections. His innovative contributions to Daewoong Pharmaceutical Co., Ltd. exemplify the impact of research and collaboration in the pharmaceutical industry. As the demand for effective treatments continues to rise, Park's work will likely play a crucial role in addressing these healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…